BSE Live
Jan 30, 16:01Prev. Close
202.65
Open Price
199.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 30, 15:57Prev. Close
202.15
Open Price
201.50
Bid Price (Qty.)
203.61 (1386)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Viyash Scientific (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 4.74 | 4.09 | |
| Net CashFlow From Operating Activities | 4.29 | 0.28 | |
| Net Cash Used In Investing Activities | -1.75 | -9.96 | |
| Net Cash Used From Financing Activities | -0.70 | 10.69 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 1.84 | 1.01 | |
| Cash And Cash Equivalents Begin of Year | 1.01 | 0.00 | |
| Cash And Cash Equivalents End Of Year | 2.85 | 1.01 |
02.12.2025
Sequent Scienti Standalone September 2025 Net Sales at Rs 34.03 crore, down 18.96% Y-o-Y
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
21.05.2025
Sequent Scienti Standalone March 2025 Net Sales at Rs 42.33 crore, up 15.12% Y-o-Y
24.02.2025
Sequent Scienti Consolidated December 2024 Net Sales at Rs 390.81 crore, up 18.66% Y-o-Y